News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
The impact of post-remission G-CSF use in the phase 3 studies of venetoclax in AML
Courtney D. DiNardo/faculty.mdanderson.org
Dec 6, 2024, 15:22

The impact of post-remission G-CSF use in the phase 3 studies of venetoclax in AML

Mohamed Benlazar, Professor of Hematology at Sidi Bel Abbès University Hospital, shared a post on X:

“The impact of post-remission G-CSF use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed AML |American Journal of Hematology | Blood Research Journal | Wiley Online Library.”

The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia

Authors: Courtney D. DiNardo, Keith W. Pratz, Panayiotis Panayiotidis, Xudong Wei, Vladimir Vorobyev, Árpád Illés, Inho Kim, Vladimir Ivanov, Grace Ku, Catherine L. Miller, Meng Zhang, Fernando Tatsch, Jalaja Potluri, Xenia Schmidt, Christian Récher

venetoclax

Árpád Illés cancer Catherine L. Miller Christian Récher Courtney D. DiNardo Fernando Tatsch Grace Ku Inho Kim Jalaja Potluri Keith W. Pratz Meng Zhang OncoDaily Oncology Panayiotis Panayiotidis venetoclax Vladimir Ivanov Vladimir Vorobyev Xenia Schmidt Xudong Wei
Special Coverage
Blog
Apr 1, 2025, 09:55
Tiago Biachi on the importance of early screening - Moffitt Cancer Center
Blog
Apr 1, 2025, 09:47
Giulia Claire Giudice: Strategies for RCC patients progressing on ICIs
Societies
Apr 1, 2025, 09:41
American Cancer Society have awarded $9 million in transportation and lodging grants, to help 63,000 cancer patients
Blog
Apr 1, 2025, 09:37
Roberta Demichelis: Thanks to all the professors who joined this first hematology congress at INCMNSZ
Blog
Apr 1, 2025, 09:30
Michelle Mitchell: Cancer Research UK’s continued commitment to funding cutting-edge science in Scotland
Blog
Apr 1, 2025, 09:22
Estela Rodriguez: Best Happy Doctors Day gift
Blog
Apr 1, 2025, 09:16
Join the IASLC International Mentorship Program
Blog
Apr 1, 2025, 09:13
Parker Institute for Cancer Immunotherapy Welcomes Karen Knudsen as Chief Executive Officer
Blog
Apr 1, 2025, 09:10
Cristian Massacesi: Improving global healthcare goes beyond expanding treatment access
Insight
Apr 1, 2025, 09:05
Yan Leyfman: CAR NK Cells - The Future of Cancer and Autoimmune Therapy? 
Career
Apr 1, 2025, 08:52
Karen Knudsen: Honored to share that I’ve taken the helm of Parker Institute for Cancer Immunotherapy as CEO
Blog
Apr 1, 2025, 08:44
Aman Shrestha: Chronic morbidity levels and associated factors among older adults in western Nepal